349 related articles for article (PubMed ID: 30661296)
21. Significance of Aspergillus spp. isolation from lower respiratory tract samples for the diagnosis and prognosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
He HY; Chang S; Ding L; Sun B; Li F; Zhan QY
Chin Med J (Engl); 2012 Sep; 125(17):2973-8. PubMed ID: 22932166
[TBL] [Abstract][Full Text] [Related]
22. Invasive Pulmonary Aspergillosis: Risks for Acquisition and Death in a Community Hospital.
Lane M; Szymeczek MA; Sherertz R; Meurtos K; Sciarretta JD; Davis JM
Surg Infect (Larchmt); 2018 Oct; 19(7):667-671. PubMed ID: 30227087
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
Chong WH; Saha BK; Tan CK
J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
[TBL] [Abstract][Full Text] [Related]
24. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
Huang L; He H; Jin J; Zhan Q
BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
[TBL] [Abstract][Full Text] [Related]
25. Altered CD8(+) T-cell counts as an early predictor of prognosis in critically ill immunocompromised patients with invasive pulmonary aspergillosis.
Cui N; Wang H; Long Y; Liu D
Chin Med J (Engl); 2014; 127(1):36-42. PubMed ID: 24384421
[TBL] [Abstract][Full Text] [Related]
26. CD8⁺ T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis.
Cui N; Wang H; Long Y; Liu D
Crit Care; 2013 Jul; 17(4):R157. PubMed ID: 23883548
[TBL] [Abstract][Full Text] [Related]
27. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
[No Abstract] [Full Text] [Related]
28. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.
Shah MM; Hsiao EI; Kirsch CM; Gohil A; Narasimhan S; Stevens DA
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):147-152. PubMed ID: 29454654
[TBL] [Abstract][Full Text] [Related]
29. Severe Influenza With Invasive Pulmonary Aspergillosis in Immunocompetent Hosts: A Retrospective Cohort Study.
Duan Y; Ou X; Chen Y; Liang B; Ou X
Front Med (Lausanne); 2020; 7():602732. PubMed ID: 33537328
[No Abstract] [Full Text] [Related]
30. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
Guinea J; Torres-Narbona M; Gijón P; Muñoz P; Pozo F; Peláez T; de Miguel J; Bouza E
Clin Microbiol Infect; 2010 Jul; 16(7):870-7. PubMed ID: 19906275
[TBL] [Abstract][Full Text] [Related]
31. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
[TBL] [Abstract][Full Text] [Related]
32. Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
Lugosi M; Alberti C; Zahar JR; Garrouste M; Lemiale V; Descorps-Desclère A; Ricard JD; Goldgran-Tolédano D; Cohen Y; Schwebel C; Vésin A; Timsit JF; Azoulay E
J Infect; 2014 Sep; 69(3):284-92. PubMed ID: 24924557
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
34. Application of a parametric model in the mortality risk analysis of ICU patients with severe COPD.
He H; Sun Y; Sun B; Zhan Q
Clin Respir J; 2018 Feb; 12(2):491-498. PubMed ID: 27606821
[TBL] [Abstract][Full Text] [Related]
35. Intensive care management of influenza-associated pulmonary aspergillosis.
Koehler P; Bassetti M; Kochanek M; Shimabukuro-Vornhagen A; Cornely OA
Clin Microbiol Infect; 2019 Dec; 25(12):1501-1509. PubMed ID: 31102782
[TBL] [Abstract][Full Text] [Related]
36. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
[No Abstract] [Full Text] [Related]
37. [Invasive pulmonary aspergillosis in influenza].
Kolwijck E; Scheper H; Beuving J; Kuijper EJ; van der Hoeven JG; Verweij PE
Ned Tijdschr Geneeskd; 2015; 159():A7431. PubMed ID: 25714763
[TBL] [Abstract][Full Text] [Related]
38. Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome.
Hu L; Kong Q; Yue C; Xu X; Xia L; Bian T; Liu Y; Zhang H; Ma X; Yin H; Sun Q; Gao Y; Ye Y; Li J
Front Immunol; 2021; 12():576640. PubMed ID: 34025635
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.
Rodríguez A; Ferri C; Martin-Loeches I; Díaz E; Masclans JR; Gordo F; Sole-Violán J; Bodí M; Avilés-Jurado FX; Trefler S; Magret M; Moreno G; Reyes LF; Marin-Corral J; Yebenes JC; Esteban A; Anzueto A; Aliberti S; Restrepo MI; ;
Respir Care; 2017 Oct; 62(10):1307-1315. PubMed ID: 28698265
[TBL] [Abstract][Full Text] [Related]
40. Influenza in patients with respiratory failure admitted to intensive care units in Poland and the use of extracorporeal respiratory support: a survey-based multicenter study.
Smiechowicz J; Barteczko-Grajek B; Adamik B; Bojko J; Gozdzik W; Lipinska-Gediga M
BMC Infect Dis; 2021 Sep; 21(1):954. PubMed ID: 34525950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
